Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancer
Dig Vijay Kumar Yarlagadda, Zhenghan Wang, Hui Jiang…·Joan Massagué
This study identifies developmental reversion to embryonic nephrogenesis in kidney cancer cells as a mechanism of resistance to immune checkpoint inhibitors.